Effect of treatment for Chlamydia trachomatis during pregnancy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objectives: To screen and treat chlamydial infection in pregnant women in order to assess the effects of therapeutic intervention on the outcome of Chlamydia trachomatis‐infected pregnancy. Methods: Enrolled in the study were 350 women in the first to third trimesters of pregnancy. Endocervical swabs were collected for C. trachomatis diagnosis by DFA and PCR. A few STD infections, viz.: Neisseria gonorrhoeae, Candida spp., bacterial vaginosis, Trichomonas vaginalis and Treponema pallidum were ruled out. After excluding 22 patients infected with other sexually transmitted infections, a cohort of 328 pregnant women comprised the study population. Anti‐chlamydial treatment (viz.: oral therapy with erythromycin stearate, 500 mg 4 times daily for 7 days) was given to 17 women (group I) and their partners. Fifteen patients of group I were retested by DFA and PCR assay for C. trachomatis infection 2 weeks following therapy. Other Chlamydia‐positive patients (n=42) who were lost to follow‐up were classified as untreated positive cases (group II) while group III included C. trachomatis negative cases (n=269). Data on obstetric outcome were recorded in a total of 164 cases. Statistical comparison of the data were done using the χ2‐test and means were compared using Student's t‐test. Results: Among the 350 pregnant women enrolled initially for the study, C. trachomatis positivity was found to be 18.8% (n=66) in the endocervix by DFA and PCR assay. Co‐infection with Candida spp., bacterial vaginosis, T. vaginalis and T. pallidum was 2.0%, 1.7%, 1.7% and 0.5%, respectively. None of the pregnant women was infected with N. gonorrhoeae. Pregnant women at an increased risk of chlamydial infection included those who had multiple births and were in second trimester of pregnancy. Fifteen patients of group I became Chlamydia‐negative following treatment. Data on obstetric outcome were recorded in 11, 26 and 127 patients of groups I, II and III, respectively. The mean duration of gestation for premature deliveries was found to be significantly higher in group I in comparison with group II [35.5 vs. 33.1 weeks (P<0.05)], thereby showing an improved effect of treatment on pregnancy outcome. The mean of low birth weight births was higher in group I compared with group II (2200.0 vs. 2113.3 g), however, this was statistically non‐significant. Stillbirths were significantly higher among group II in comparison with group III [11.5% vs. 4.7% (χ2=1.79; P<0.5)]. No stillbirths were recorded in patients who had taken anti‐chlamydial treatment. Conclusions: Our findings suggest that routine screening and treatment of C. trachomatis infection in pregnant women, especially those in high risk groups, should be mandatory to reduce the adverse effects on obstetric outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery
COTCH, M. F., PASTOREK, J. G., NUGENT, R. P., HILLIER, S. L., GIBBS, R. S., MARTIN, D. H., ESCHENBACH, D. A., EDELMAN, R., CAREY, C. J., REGAN, J. A., et al. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199707000-00008 · Cited by 836
Chlamydia trachomatis infection and pregnancy outcome
Sweet, R. L., Landers, D. V., Walker, C., & Schachter, J. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90338-3 · Cited by 209
Sexually transmitted diseases and adverse outcomes of pregnancy
Goldenberg, R. L., Andrews, W. W., Yuan, A. C., MacKay, H. T., & Louis, M. E. S. (1997) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30182-9 · Cited by 166
Cited by
2015 European guideline on the management of Chlamydia trachomatis infections
Lanjouw, E., Ouburg, S., de Vries, H., Stary, A., Radcliffe, K., & Unemo, M. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415618837 · Cited by 328
Mullick, S. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2002.004077 · Cited by 261
Adachi, K., Nielsen-Saines, K., & Klausner, J. D. (2016) · BioMed Research International · doi:10.1155/2016/9315757 · Cited by 118
“In contrast, a few studies, including ones from India, Nepal, and South Africa, did not find significant associations, possibly due to issues with sample size and/or low prevalence of C. trachomatis [21, 38, 41, 43] (Table 1).”
MethodResultInfluentialAdachi, K. N., Nielsen-Saines, K., & Klausner, J. D. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.531073 · Cited by 66
“(53) New Delhi, India 2003 Yes 350 Obs/Prosp Erythromycin 500mg QID × 7 days Both 1st−3rd trimester (most tx 2nd trimester) CT/cervical DFA, PCR Also NG, candida, BV, trich, syphilis testing Tx group vs.”
BackgroundMethodResultInfluentialOlaleye, A. O., Babah, O. A., Osuagwu, C. S., Ogunsola, F. T., & Afolabi, B. B. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.10.002 · Cited by 47
Metadata
- Authors
- Rastogi, S., Das, B., Salhan, S., & Mittal, A.
- Venue
- International Journal of Gynecology & Obstetrics
- Publisher
- Wiley
- Published
- 2003-01-28
- Volume
- 80
- Issue
- 2
- Pages
- 129-137
- ISSN
- 0020-6695 (ISSN-L)
- 0020-7292
- 1879-3479
- OpenAlex
- W1976875527
- Cited by
- 57
- References
- 3
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of treatment for Chlamydia trachomatis during pregnancy. https://app.cochat.ai/papers/10.1016/s0020-7292(02)00371-5
- The paper
- Rastogi, S., Das, B., Salhan, S., & Mittal, A. (2003). Effect of treatment for Chlamydia trachomatis during pregnancy. International Journal of Gynecology & Obstetrics. https://doi.org/10.1016/s0020-7292(02)00371-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.